Accela Naz 9034 260820 1680x1340

13.11.2026

Accela: A New Generation of Linear Accelerator Technology

What does it take to bring a new generation of radiotherapy from the drawing board to the patient?
In this session, experts from USZ and Siemens Healthineers will share their perspectives on innovation, technical validation, and clinical translation.

Date

13 Nov 2026

Time

15:30 - 17.30

Type

Hybrid

Location

University Hospital Zurich

Lecture hall

Grosser Hörsaal Path / D22

With the introduction of Accela at the University Hospital Zurich, a new generation of radiotherapy technology is entering the clinic. As one of the first centres worldwide to implement this innovative linear accelerator, the USZ is taking an important step towards the future of highly precise cancer treatment.

Accela combines precision, advanced imaging and exceptional treatment speed. This opens new possibilities for complex treatments, including stereotactic irradiation of multiple targets, while significantly reducing treatment times. Technologies such as Spine-Tracking provide continuous image-guided monitoring during treatment, while adaptive radiotherapy approaches enable treatment to be tailored to the patient’s anatomy of the day.

This session explores the journey from technological innovation to clinical implementation — and ultimately to patient benefit.

Register

Please register by 09.11.2026.

13.11.2026

15:30

Part I – Shaping the Future of Radiation Oncology: Cooperation Between Siemens Healthineers and USZ

Moderated by Stephanie Tanadini-Lang, University Hospital Zurich, Switzerland

15:30

The USZ Perspective: Driving Innovation in Radiation Oncology

Christian Baumann, Medical Co-Director, University Hospital Zurich, Switzerland

15:35

The Industry Perspective: Advancing the Future of Radiotherapy

Arthur Kaindl, Head of Varian, a Siemens Healthineers company

15:45

The Clinical Perspective: Translating Innovation into Patient Care

Matthias Guckenberger, University Hospital Zurich, Switzerland

15:50

Part II – From Technology to Patient Benefit: Accela at USZ

Moderated by Stephanie Tanadini-Lang, University Hospital Zurich, Switzerland

15:50

Building the Foundation: Technical Validation of the Accela system

Riccardo Dal Bello, University Hospital Zurich, Switzerland

16:10

From Innovation to Patient Benefit: Translating the Technology into Clinical Cancer Care

Jonas Willmann, University Hospital Zurich, Switzerland

16:30

Optional – Innovation in Action: A Guided Tour of the New Linac

Klara Kefer, Stefanie Kaser, Michael Baumgartl, University Hospital Zurich, Switzerland

Six 10-minute guided tours will be offered, with 10 participants per tour.

16:30

Closing Apéro